$25.350
-1.044 (-4.12%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
COLL Prediction & Forecast by Similar Chart Analysis
Alphio's COLL stock price prediction model matches the current Collegium Pharmaceutical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.37 (+0.07%). The 1-week path is $25.41 (+0.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Collegium Pharmaceutical Inc Stock?
Collegium Pharmaceutical Inc is not a good buy right now due to significant recent declines and negative sentiment. The current price is $25.35, which is down 44.32% year-to-date, and the RSI is at a very low 19.302, indicating oversold conditions but also a lack of buying momentum. The company's recent Q2 earnings showed a revenue of $199.9 million, which missed expectations of $201.2 million, highlighting ongoing challenges in the pain business. Additionally, insider selling has increased by 145.95% over the last month, suggesting a lack of confidence from those closest to the company. The main risk is the company's declining performance in its pain franchise, which has faced pricing pressures, contributing to a negative outlook.
COLL stock price ended at $25.35 on Friday, after losing -4.12%
Collegium Pharmaceutical Inc (COLL) last closed at $25.35, losing -4.12%. These facts feed the 1-day and 1-week COLL price prediction above.
Analyst Consensus
Collegium Pharmaceutical Inc (COLL): 7 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Collegium Pharmaceutical Inc (COLL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches COLL, ranked by similarity.
Seasonality analysis for COLL
Historically the probability of a positive August return for COLL is 68.25%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for COLL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $22.87 | $28.64 | $32.85 | +12.96% |
| Sep 2026 | $28.86 | $34.67 | $38.55 | +36.76% |
| Oct 2026 | $27.53 | $28.64 | $29.52 | +12.96% |
| Nov 2026 | $33.79 | $39.25 | $42.11 | +54.83% |
| Dec 2026 | $31.78 | $34.66 | $35.48 | +36.74% |
In 2026, Collegium Pharmaceutical Inc (COLL) is projected to range from $22.87 to $42.11.
Collegium Pharmaceutical Inc 2026 monthly forecast
In Aug 2026, Collegium Pharmaceutical Inc is projected to average $28.64, with a low of $22.87 and high of $32.85.
In Sep 2026, Collegium Pharmaceutical Inc is projected to average $34.67, with a low of $28.86 and high of $38.55.
In Oct 2026, Collegium Pharmaceutical Inc is projected to average $28.64, with a low of $27.53 and high of $29.52.
In Nov 2026, Collegium Pharmaceutical Inc is projected to average $39.25, with a low of $33.79 and high of $42.11.
In Dec 2026, Collegium Pharmaceutical Inc is projected to average $34.66, with a low of $31.78 and high of $35.48.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.